A Female-Specific Microglial Redox Program Gates Susceptibility to Obesity

Technical Summary: A Female-Specific Microglial Redox Program Gates Susceptibility to Obesity

Problem Statement
Chronic consumption of high-fat diets (HFD) drives obesity by altering hypothalamic circuits that regulate energy balance. While hypothalamic microglia are known to sense circulating lipids and contribute to diet-induced neuroinflammation and weight gain, the mechanisms by which their intracellular metabolic programs adapt to acute and chronic nutrient excess remain unclear. Furthermore, the pronounced sex differences in obesity susceptibility—where females often exhibit delayed weight gain compared to males despite similar caloric intake—suggest that microglial responses may be sexually dimorphic, yet this has not been systematically characterized at the metabolic and signaling levels.

Methodology
The study utilized a multi-omics and genetic approach in C57BL/6 mice to dissect sex-specific microglial responses to HFD.

• Experimental Models: Male and female mice were fed either a standard chow diet or a 60% kcal high-fat diet for acute (1–3 days) or chronic (6 weeks) periods.
• Genetic Manipulation: To probe specific signaling nodes, the authors generated microglia-specific conditional knockdown (KD) mice using the Cx3cr1-CreERT2 system crossed with floxed alleles for Raptor (MG-RaptorKD, disrupting mTORC1), Tfam (MG-TFAMKD, disrupting mitochondrial transcription), and Hif1α (MG-HIF1αKD).
• Omics and Profiling:
  • scRNA-seq: Single-cell RNA sequencing of FACS-sorted hypothalamic microglia (CD11b+/CD45low) after 3 days of HFD to identify transcriptional clusters and pathway enrichment.
  • Metabolomics/Lipidomics: Untargeted mass spectrometry on isolated microglia to profile metabolites (e.g., glutathione, polyamines) and lipid species.
  • Kinome Profiling: PamChip peptide microarrays to assess global kinase activity changes.
  • Bulk RNA-seq and Proteomics: To validate transcriptomic and protein-level changes.
• Functional Assays:
  • Imaging: Two-photon microscopy for process motility, electron microscopy for mitochondrial ultrastructure, and immunostaining for lipid droplets (Plin2).
  • Respirometry: High-resolution O2k respirometry on permeabilized microglia to measure mitochondrial oxygen consumption.
  • ROS Quantification: Flow cytometry using CellROX Deep Red to measure intracellular reactive oxygen species (ROS).
  • Electrophysiology: Multi-electrode array (MEA) recordings from acute hypothalamic slices to assess neuronal network activity.
  • Phenotyping: Longitudinal monitoring of body weight, food intake, and body composition (fat vs. lean mass) via EchoMRI.

Key Results

1. Sex-Divergent Metabolic Responses: Upon acute HFD exposure (3 days), female hypothalamic microglia rapidly engaged a protective metabolic program characterized by increased antioxidant capacity, mitochondrial network remodeling (fragmentation), and lipid droplet accumulation. In contrast, male microglia showed suppression of these metabolic pathways and a tendency toward immune-related activation.
2. Antioxidant Reprogramming in Females: Metabolomic analysis revealed that female microglia accumulated antioxidant metabolites (spermidine, cadaverine) and maintained glutathione levels, whereas males showed signs of glutathione depletion. Despite these shifts, ROS levels remained stable in both sexes at 3 days, suggesting a maintained redox homeostasis in females via enhanced capacity rather than just suppression.
3. Mitochondrial Remodeling: Female microglia exhibited mitochondrial fragmentation (shorter mitochondria) and a reduction in OXPHOS complex proteins, indicating a structural and functional reorganization distinct from the male response.
4. The Role of mTORC1: Kinome profiling identified a rapid, sex-specific activation of the mTORC1 pathway (and its downstream effector p70S6K) in female microglia, which was absent or reduced in males.
   • Loss of mTORC1 (MG-RaptorKD): Knocking down Raptor in female microglia prevented the HFD-induced rise in ROS and prolonged the initial antioxidant state. Crucially, MG-RaptorKD females gained significantly less weight and fat mass over 6 weeks of HFD compared to controls, without changes in food intake or lean mass.
   • Mechanism: The protective effect of Raptor KD was linked to reduced mitochondrial respiration and lower ROS production.
5. Mitochondrial Dependence: The study demonstrated that the pro-oxidant effect of mTORC1 is mitochondria-dependent. Knocking down Tfam (MG-TFAMKD) in female microglia mimicked the Raptor KD phenotype: it reduced mitochondrial respiration, lowered ROS levels, and protected against HFD-induced weight gain. Conversely, knocking down Hif1α did not alter weight gain, indicating the effect is not mediated by HIF-1α-driven glycolysis.
6. Neuronal Impact: MG-RaptorKD mice exhibited decreased spontaneous neuronal activity in the ventromedial and dorsomedial hypothalamus, suggesting microglial mTORC1 signaling influences synaptic circuit remodeling in response to diet.

Significance and Claims
The paper claims to identify a female-specific microglial redox program that acts as a gatekeeper for obesity susceptibility. The authors posit that:

• Female microglia initially mount a protective, antioxidant-rich metabolic state to buffer acute lipid excess, delaying weight gain.
• The activation of mTORC1 signaling serves as a "switch" that eventually dismantles this resilience by driving mitochondrial oxidative phosphorylation and ROS production, leading to the delayed onset of weight gain observed in females.
• This mechanism contrasts with the male response, which appears to engage inflammatory pathways earlier.
• The findings suggest that microglial metabolism, specifically the mTORC1-mitochondria-ROS axis, is a critical, sex-dependent regulator of energy homeostasis.
• Therapeutically, the study argues that strategies targeting inflammation (often developed in male models) may be suboptimal for females, and that sex-specific metabolic interventions targeting microglial redox status could be a viable avenue for obesity prevention.

The authors maintain modesty regarding the upstream triggers of these sex differences (e.g., specific circulating lipids or hormonal signals) and acknowledge that their genetic models target microglia globally rather than strictly within the hypothalamus, though the phenotypes strongly implicate central mechanisms.